Search

everythinglearnresearchcommunity

for

Search:↓

Actemra is approved for a specific artery condition, HIV treatment adherence has improved, women may pay more for a hair loss product, and incorrect dosing of blood thinners can be risky.

Combining a GnRH agonist with a low-dose oral contraceptive is more effective and safer for treating hirsutism than using either alone.

Dutasteride can help treat hair loss in both men and women.

The review recommends hormone replacement therapy for women with premature ovarian insufficiency to manage symptoms and protect health, with specific approaches for different groups.

Upadacitinib may effectively treat twenty-nail dystrophy without causing pain.

Dutasteride may lower the chance of finding prostate cancer in men with enlarged prostates.

The gel improves hair regrowth and reduces irritation in alopecia areata treatment.

Thorough evaluation and surgery are crucial for managing rare ovarian tumors in postmenopausal women with high androgen levels.

Dutasteride works better than finasteride for hair loss and has mild, reversible side effects.

The combination of gemcitabine and vinorelbine is effective and safe for treating elderly patients with advanced breast cancer previously treated with anthracyclines and taxanes.

DHEA therapy improves pubic hair growth and psychological well-being in young females with central adrenal insufficiency.

Medications for enlarged prostate can cause sexual side effects like reduced libido, erectile dysfunction, and ejaculatory problems.

Epirubicin is as effective as doxorubicin for cancer treatment with less heart damage, but doesn't work on doxorubicin-resistant cancers.

The FDA did not approve a testosterone drug because of safety concerns.

Non-daily Dutasteride is more cost-effective and has lower cancer incidence than daily treatment.

Dutasteride, usually used for prostate issues and hair loss, could potentially treat Amyotrophic Lateral Sclerosis (ALS) due to its neuroprotective, antioxidant, and anti-inflammatory properties, but more testing is needed.

An ovarian tumor caused a woman's male-like symptoms, which improved after surgery.

A holistic approach, including diet and stress management, may improve androgenetic alopecia treatment outcomes.

Hair growth supplements do not reduce the effectiveness of the breast cancer treatment tamoxifen.

Excessive eyelash growth from erlotinib may indicate positive tumor response and help treat madarosis.

Upadacitinib and oral minoxidil improved Crohn's disease and hair regrowth in a patient.

Abrocitinib, a JAK inhibitor, may help treat atopic dermatitis and alopecia universalis together.

Dutasteride mesotherapy for hair loss can cause lasting bald patches.

Progestogens are essential in menopausal hormone therapy to prevent uterine cancer and must be chosen carefully based on individual needs.

Finasteride and low-dose dutasteride combo improves hair growth and reduces hair loss with no major side effects.

The treatment was not recommended due to limited effectiveness and significant side effects.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

Hormone replacement therapy improves skin health and reduces aging signs in postmenopausal women.